SEC 13F Intelligence

Rock Springs Capital Management LP / ELVN

Rock Springs Capital Management LP’s Enliven Therapeutics Inc Position

Does Rock Springs Capital Management LP own Enliven Therapeutics Inc (ELVN)? Yes — 826.5K shares worth $32M (+1.91% of its 13F portfolio) as of Q1 2026, up from 798.4K shares the prior filed quarter.

Position Value
$32M
Q1 2026
Shares
826.5K
% of Portfolio
+1.91%
Quarters Held
9
currently held

Position History ELVN

Reported value by quarter
Q1 ’24: $8MQ1 ’24Q2 ’24: $10MQ3 ’24: $11MQ3 ’24Q4 ’24: $10MQ1 ’25: $9MQ1 ’25Q2 ’25: $14MQ3 ’25: $14MQ3 ’25Q4 ’25: $12MQ1 ’26: $32MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026826.5K$32M+1.91%
Q4 2025798.4K$12M+0.63%
Q3 2025686.1K$14M+0.82%
Q2 2025701.4K$14M+0.88%
Q1 2025465.9K$9M+0.52%
Q4 2024428.6K$10M+0.37%
Q3 2024428.6K$11M+0.36%
Q2 2024428.6K$10M+0.30%
Q1 2024428.6K$8M+0.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of ELVN.